Ferric derisomaltose and tranexamic acid, combined or alone, for reducing blood transfusion in patients with hip fracture (the HiFIT trial): a multicentre, 2 × 2 factorial, randomised, double-blind, controlled trial
- Resource Type
- Article
- Source
- The Lancet Haematology; September 2023, Vol. 10 Issue: 9 pe747-e755, 9p
- Subject
- Language
- ISSN
- 23523026